5,7-dimethoxycoumarin has been researched along with Psoriasis in 1 studies
5,7-dimethoxycoumarin: has photobiological activity
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a common immune-mediated skin disorder manifesting in abnormal skin plaques, and phosphodiesterase 4 (PDE4) is an effective target for the treatment of inflammatory diseases such as psoriasis." | 1.72 | Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis. ( Hou, KQ; Huang, Y; Huang, YY; Liu, L; Luo, HB; Song, Z; Wan, G; Xiong, XF; Zhou, F, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Z | 1 |
| Huang, YY | 1 |
| Hou, KQ | 1 |
| Liu, L | 1 |
| Zhou, F | 1 |
| Huang, Y | 1 |
| Wan, G | 1 |
| Luo, HB | 1 |
| Xiong, XF | 1 |
1 other study available for 5,7-dimethoxycoumarin and Psoriasis
| Article | Year |
|---|---|
Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis.
Topics: Administration, Topical; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Mice; Phosphodiester | 2022 |